LanguaTalk

The Lancet Haematology in conversation with

Lan-Lan Smith, Editor-in-Chief, Emma Cookson, Deputy Editor, and Daniela Marín, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemolytic disease in newborns, and more.

Marc Riedl on hereditary angioedema

17 mins; April 02, 2026

Julio Delgado and Valentín Ortiz-Maldonado (Spanish version)

12 mins; March 04, 2026

Julio Delgado and Valentín Ortiz-Maldonado

12 mins; March 04, 2026

Erica Kaye and Dylan Graetz discuss expert recommendations for the conduct and appraisal of qualitative research in haematology

19 mins; February 04, 2026

Presented at ASH: API-CAT post-hoc analysis on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE

9 mins; December 31, 2025

Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation

14 mins; December 08, 2025

ASH 2025 Preview - Expert Roundtable

22 mins; December 02, 2025

Arnon Kater and Sabina Kersting on the HOVON 158/NEXT STEP phase 2 trial testing a new first-line treatment regimen for chronic lymphocytic leukaemia

24 mins; December 01, 2025

Ruben Mesa on ropeginterferon alfa-2b for hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia

11 mins; November 03, 2025

A panel of the authors on our Lancet Haematology-Lancet Regional Health Western Pacific Series on mature T-cell and natural killer-cell lymphomas

17 mins; September 14, 2025

Lan-Lan Smith, Cheryl Lai, and Daniela Marín discuss the EHA, ICML, and ISTH conferences

19 mins; August 04, 2025

Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma

21 mins; July 01, 2025

A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies

40 mins; June 13, 2025

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

15 mins; April 28, 2025

Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia

17 mins; March 31, 2025

Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe

27 mins; March 03, 2025

Dawn Swan on air pollution and venous thromboembolism

15 mins; January 29, 2025

Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis

16 mins; January 16, 2025

Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom

17 mins; December 03, 2024

Lancet Haematology 10 year anniversary - meet the editors

47 mins; October 02, 2024

Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome

8 mins; August 22, 2024

Kim Linton on follicular lymphoma

9 mins; August 07, 2024

Judy Truong on ferritin reference levels and iron deficiency

11 mins; August 05, 2024

Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML

14 mins; July 16, 2024

Banu Aygun on sickle cell anaemia

11 mins; May 23, 2024

Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia

18 mins; March 01, 2024

Elisabeth Schorb on the MARTA phase 2 trial

9 mins; February 29, 2024

Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies

13 mins; January 31, 2024

Dr Sarah O'Brien on the PREVAPIX-ALL trial

13 mins; December 20, 2023

Enrico Lopriore on haemolytic disease of the fetus and newborn

12 mins; November 29, 2023

Meletios Dimopoulos on relapsed and refractory multiple myeloma

11 mins; October 03, 2023

Eric Ohuma on haemoglobin concentrations and neonatal outcomes

16 mins; August 29, 2023

Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding

13 mins; July 31, 2023

Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma

16 mins; July 03, 2023

Alok Srivastava on fitusiran for patients with haemophilia A and B

18 mins; March 29, 2023

Emmanuela E Ambrose on stroke prevention in children with sickle cell disease

11 mins; March 02, 2023

Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes

22 mins; January 30, 2023

Xiao-Jun Huang on cellular therapy in China

28 mins; November 28, 2022

Glenn Pierce on haemophilia care in LMICs

34 mins; August 30, 2022

Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders

12 mins; June 30, 2022

Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline

15 mins; March 07, 2022

Fredrik Schjesvold on OCEAN phase 3

12 mins; January 31, 2022

Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia

11 mins; November 25, 2021

Raul Cordoba on haematological malignancies in older people

16 mins; November 03, 2021

Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria

9 mins; September 21, 2021

Zuguo Mei and Gary Brittenham on iron deficiency

8 mins; July 27, 2021

Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care

29 mins; May 11, 2021

Eugenia Trigoso Arjona (in English) on nursing and haematological care

28 mins; May 11, 2021

Nada Hamad on inclusion and diversity in haematology

30 mins; February 23, 2021

Dr Judith Boer on lymphoblastic leukaemia in children

10 mins; December 22, 2020

The Lancet Haematology in conversation with

Useful pages

Find a tutor

Languages